Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
NCT06246396Phase 4Recruiting
- Sponsor
- University of Florida
- Start
- Jan 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of minocycline in hypertension (HTN), sponsored by University of Florida. Started Jan 2025; status: recruiting.
02
Drugs
minocycline
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06246396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06246396.